
In a strategic move aimed at raising the standard of medical services and broadening the reach of healthcare, EVA Pharma, the leading Egyptian pharmaceutical company, has signed a memorandum of Understanding (MoU) with Al-Ahly Medical Company (AMC), the medical arm of the National Bank of Egypt (NBE), to strengthen collaboration between the two entities in delivering integrated patient care and enhancing the efficiency of healthcare professionals.
Under the MoU, EVA Pharma will enable patients of AMC to benefit from its "Patient Support Programs," which cover vital specialties including cardiology, metabolism, immunology, oncology, and orthopedics and pain management.
The MoU also includes advanced training programs to develop the scientific and practical skills of physicians and medical case management teams.
Dr. Abram Wagih, Egypt Cluster head, EVA Pharma, said the step reflects the company's strategy of putting patients first, adding: "Through our partnership with AMC, we seek to make a tangible, positive impact on patients' lives by removing barriers to accessing innovative treatments through dedicated support programs."
He added: "Our commitment does not stop at providing medicines. It extends to empowering the entire healthcare system by investing in developing physicians' capabilities and updating their knowledge, ensuring treatment services that meet global standards."
For his part, Prof. Dr. Adel Allam, CEO of AMC, said: "I firmly believe that our professionals will continue to meet the expectations of our stakeholders in the future, because, whatever we do, we do with passion and devotion”
The MoU also provides regular medical forums to share the latest scientific guidelines with pharmacists and physicians, along with a mechanism for exchanging statistical and quantitative data to study cases and identify patients eligible for support programs. This will help deliver free therapeutic initiatives and medical offers that meet the actual needs of targeted patients.
About EVA PharmaEVA Pharma is dedicated to improving access to affordable, high-quality medicines around the world, focusing on three core pillars: innovation, development and sustainable access. The company leverages cutting-edge technology at two research centers bringing first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products.
With a 5,000-strong team of professionals, EVA Pharma produces more than one million healthcare products a day at four state-of-the-art manufacturing facilities, which are internationally recognized for innovation, and have been approved by multiple regulatory agencies.
Guided by a relentless drive to ensure sustainable access to pressing yet unmet disease areas, the company’s product portfolio focuses on twelve therapeutic areas: Anti-infectives, metabolic health, bone, neuroscience, oncology, respiratory, gynecology, urology and andrology, pediatrics, ophthalmology, gastrointestinal tract, family medicine to meet both local and international demand.
EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 40 countries worldwide.
About Al-Ahly Medical Company (AMC)
Al Ahly Medical Company (AMC)—the medical arm of the National Bank of Egypt (NBE)—is one of the leading providers of integrated healthcare solutions, committed to delivering superior medical services tailored specifically to meet the needs of corporations and individuals alike, and honored to serve over 600,000 beneficiaries across various sectors.
Through its comprehensive healthcare management system, the company offers a diverse suite of medical services, including corporate medical insurance programs customized to the needs of each company, medical discount cards that guarantee advanced care with the highest efficiency and most suitable cost, as well as an extensive, accredited nationwide medical network encompassing over 4,800 medical service providers, including top hospitals, specialized centers, clinics, pharmacies, and other healthcare providers.
Driven by its firm belief that "your health is our priority and responsibility," the company continues to develop its healthcare ecosystem by digitizing its services to ensure an exceptional experience that provides maximum comfort and accessibility for thousands of clients and success partners.
We empower the fight for health and well being as a human right.
Subscribe for our latest news and updates
For adverse events reporting, please contact us on
PV.Report@evapharma.com